| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 133.81B | 132.28B | 125.08B | 119.18B | 117.75B | 99.92B |
| Gross Profit | 44.15B | 42.65B | 41.62B | 37.88B | 37.35B | 33.48B |
| EBITDA | 21.55B | 21.63B | 21.50B | 18.60B | 19.28B | 16.30B |
| Net Income | 12.90B | 13.11B | 13.19B | 9.97B | 9.05B | 10.00B |
Balance Sheet | ||||||
| Total Assets | 256.08B | 267.25B | 269.82B | 236.53B | 228.98B | 220.21B |
| Cash, Cash Equivalents and Short-Term Investments | 70.61B | 78.71B | 90.62B | 76.89B | 75.82B | 67.16B |
| Total Debt | 450.00M | 745.00M | 989.00M | 1.27B | 1.64B | 1.54B |
| Total Liabilities | 40.49B | 43.95B | 49.93B | 40.14B | 41.31B | 43.54B |
| Stockholders Equity | 188.43B | 195.22B | 187.15B | 166.27B | 160.29B | 151.50B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 883.00M | 15.35B | 7.00B | 10.05B | 11.30B |
| Operating Cash Flow | 0.00 | 12.01B | 22.78B | 16.61B | 14.28B | 16.21B |
| Investing Cash Flow | 0.00 | -16.28B | -5.78B | -12.30B | -6.66B | -7.26B |
| Financing Cash Flow | 0.00 | -15.23B | -6.78B | -9.16B | -4.11B | -8.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥175.14B | 10.40 | ― | 3.50% | 3.85% | -1.53% | |
74 Outperform | ¥169.10B | 14.73 | ― | 2.84% | 6.06% | 19.76% | |
73 Outperform | ¥80.91B | 3.80 | ― | 1.52% | 10.51% | 2.95% | |
69 Neutral | ¥2.37T | 13.66 | 11.64% | 1.52% | 9.81% | 32.64% | |
68 Neutral | ¥421.81B | 7.90 | 13.71% | 3.38% | 0.29% | 27.84% | |
65 Neutral | ¥357.80B | 10.69 | 8.14% | 2.61% | -1.45% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |